Kalyan Vara GaneshNadimintiMD

PubMed

• A gain-of-function p53 mutant synergizes with oncogenic NRAS to promote acute myeloid leukemia in mice.
  Rajagopalan, A., Feng, Y., Gayatri, M., Ranheim, E., Klungness, T., Matson, D., Lee, M., Jung, M., Zhou, Y., Gao, X., Nadiminti, K., Yang, D., Tran, V., Padron, E., Mi...> ;The Journal of Clinical Investigation. 2023 Dec 15
• 6 citations
  Inflammatory CD4/CD8 double-positive human T cells arise from reactive CD8 T cells and are sufficient to mediate GVHD pathology.
  Nicholas J Hess, David P Turicek, Jeremiah Riendeau, Sean J McIlwain, Emmanuel Contreras Guzman, Kalyan Nadiminti, Amy Hudson, Natalie S Callander, Melissa C Skala, Je...> ;Science Advances. 2023 Mar 24
• Haploidentical Donor Blood or Marrow Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms: Results from a North American Collaboration.
  Tania Jain, Hua-Ling Tsai, Hany Elmariah, Pankit Vachhani, Theodoros Karantanos, Sarah Wall, Lukasz Gondek, Asad Bashey, Alla Keyzner, Roni Tamari, Michael Grunwald, S...> ;Research Square. 2023 Mar 21
• 28 citations
  Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
  Aaron T Gerds, Jason Gotlib, Haris Ali, Prithviraj Bose, Andrew Dunbar, Amro Elshoury, Tracy I George, Krishna Gundabolu, Elizabeth Hexner, Gabriela S Hobbs, Tania Jai...> ;Journal of the National Comprehensive Cancer Network. 2022 Sep 1
• A Case of Isolated Myeloid Sarcoma Associated With GermlineT790M Variant: The Importance of Recognizing Potential Germline Variants on Somatic Tumor Sequencing Panels.
  Margaret Walker, Matthew Folstad, Kelcy Smith-Simmer, Erica Reinig, Kalyan Nadiminti, Lauren Lovrien, Jane E Churpek, Lauren G Banaszak> ;Journal of Hematology. 2022 Apr 1
• 1 citations
  A novel Iowa-Mayo validated composite risk assessment tool for allogeneic stem cell transplantation survival outcome prediction.
  Kalyan Nadiminti, Kimberly J. Langer, Ehsan Shabbir, Mehrdad Hefazi, Lindsay Dozeman, Yogesh Jethava, Bradley T. Loeffler, Hassan B. Alkhateeb, Mark R. Litzow, Mrinal ...> ;Blood Cancer Journal. 2021 Nov 20
• 17 citations
  Asxl1loss cooperates with oncogenic Nras in mice to reprogram immune microenvironment and drive leukemic transformation.
  Xiaona You, Fabao Liu, Moritz Binder, Alexis Vedder, Terra L. Lasho, Zhi Wen, Xin Gao, Evan Flietner, Adhithi Rajagopalan, Yun Zhou, Christy Finke, Abhishek A. Mangaon...> ;Blood. 2021 Oct 26
• 10 citations
  Characteristics and outcomes of therapy-related myeloid neoplasms following autologous stem cell transplantation for multiple myeloma.
  Kalyan Nadiminti, M. Hasib Sidiqi, Kapil Meleveedu, Hassan B. Alkhateeb, William J. Hogan, Mark R. Litzow, Mrinal M. Patnaik, Shaji Kumar, Morie A. Gertz, Dong Chen, M...> ;Blood Cancer Journal. 2021 Mar 19
• 8 citations
  PD-1/PD-L1 expression in extramedullary lesions of acute myeloid leukemia
  Kapil Meleveedu, Dong Chen, Kalyan Nadiminti, Hasib Sidiqi, Shakila P. Khan, Hassan B. Alkhateeb, Mithun Vinod Shah, Mrinal M. Patnaik, William J. Hogan, Kebede H. Beg...> ;Leukemia & Lymphoma. 2021 Feb 23
• 30 citations
  Identification and Characterization of Tumor-Initiating Cells in Multiple Myeloma
  Minjie Gao, Hua Bai, Yogesh Jethava, Yujie Wu, Yuqi Zhu, Ye Yang, Jiliang Xia, Huojun Cao, Reinaldo Franqui-Machin, Kalyan Nadiminti, Gregory S. Thomas, Mohamed E. Sal...> ;Journal of the National Cancer Institute. 2020 May 1
• 1 citations
  t(15; 17) associated with primary myelofibrosis: a case report of an unusual clinical presentation and diagnostic dilemma.
  Kalyan Nadiminti, Margarida Silverman, Sharathkumar Bhagavathi, Praveen Vikas> ;Oncotargets and Therapy. 2019 Jul 11
• 8 citations
  Autologous stem cell transplantation in patients with AL amyloidosis with impaired renal function.
  M. Hasib Sidiqi, Kalyan Nadiminti, Abdullah S. Al Saleh, Kapil Meleveedu, Francis K. Buadi, Angela Dispenzieri, Rahma Warsame, Martha Q. Lacy, David Dingli, Nelson Leu...> ;Bone Marrow Transplantation. 2019 Apr 8
• 28 citations
  Alteration of mitochondrial biogenesis promotes disease progression in multiple myeloma.
  Xin Zhan, Wenjie Yu, Reinaldo Franqui-Machin, Melissa L. Bates, Kalyan Nadiminti, Huojun Cao, Brad A. Amendt, Yogesh Jethava, Ivana Frech, Fenghuang Zhan, Guido Tricot> ;Oncotarget. 2017 Nov 27
• 5 citations
  VTD-melphalan is well tolerated and results in very high rates of stringent CR and MRD-negative status in multiple myeloma.
  Kalyan Nadiminti, Kamal Kant Singh Abbi, Sarah L. Mott, Lindsay Dozeman, Annick Tricot, Allyson Schultz, Sonya Behrends, Fenghuang Zhan, Guido J Tricot> ;Oncotargets and Therapy. 2017 Jan 6
• 9 citations
  Potential pitfalls of serum free light chain analysis to assess treatment response for multiple myeloma.
  Kamal Kant Singh Abbi, Margarida Silverman, Umar Farooq, Annick Tricot, Lindsey Dozeman, Kalyan Nadiminti, Matthew D. Krasowski, Guido J Tricot> ;British Journal of Haematology. 2016 Aug 1
• 2 citations
  Intraocular bevacizumab in the treatment of choroidal metastases from breast cancer
  Kalyan Nadiminti, José Pablo Leone> ;BMJ Case Reports. 2016 Jul 18
• Join now to see all

Lectures

• A Single Autologous Stem Cell Transplant (ASCT) Followed By Two Years of Post-Transplant Therapy in Recently Diagnosed Elderly Multiple Myeloma (MM) Patients. Safety a... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018